These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37337223)

  • 1. PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration.
    Zhang J; Ma Q; Yu Q; Xiao F; Zhang Z; Feng H; Liang C
    Biol Direct; 2023 Jun; 18(1):33. PubMed ID: 37337223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
    Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
    Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.
    Cheng CC; Chou KF; Wu CW; Su NW; Peng CL; Su YW; Chang J; Ho AS; Lin HC; Chen CG; Yang BL; Chang YC; Chiang YW; Lim KH; Chang YF
    Lung Cancer; 2018 Feb; 116():80-89. PubMed ID: 29413056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation.
    Fararjeh AS; Chen LC; Ho YS; Cheng TC; Liu YR; Chang HL; Chang HW; Wu CH; Tu SH
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
    Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
    J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
    Yang X; Lin F; Gao F
    Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
    Bo C; Li N; He L; Zhang S; An Y
    Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression.
    Hu Q; Lu YY; Noh H; Hong S; Dong Z; Ding HF; Su SB; Huang S
    Oncogene; 2013 Aug; 32(34):3933-43. PubMed ID: 22986534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression.
    Huang Y; Zheng Y; Yao L; Qiao F; Hou Y; Hu X; Li D; Shao Z
    Cancer Sci; 2022 Nov; 113(11):3801-3813. PubMed ID: 35579257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway.
    Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2647-2658. PubMed ID: 32196615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway.
    Yan G; Chang Z; Wang C; Gong Z; Xin H; Liu Z
    Dig Liver Dis; 2022 Jan; 54(1):125-135. PubMed ID: 34053876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
    Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker.
    Liu Y; Li Y; Zhao Y; Liu Y; Fan L; Jia N; Zhao Q
    Mol Med Rep; 2019 Jul; 20(1):125-134. PubMed ID: 31115508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis.
    Liu W; Li S
    Onco Targets Ther; 2021; 14():1861-1872. PubMed ID: 33737811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV promotes keratinocyte proliferation and migration through upregulating lncRNA H19 recruited ILF3 to enhance the stability of CDK4 mRNA.
    Wang DD; Zhang LZ; Pang CJ; Ye JZ
    Kaohsiung J Med Sci; 2023 Aug; 39(8):811-823. PubMed ID: 37132584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis.
    Han S; Song L; Chen Y; Hou M; Wei X; Fan D
    Exp Cell Res; 2020 Aug; 393(2):112087. PubMed ID: 32407730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
    Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
    RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.
    Li K; Wu JL; Qin B; Fan Z; Tang Q; Lu W; Zhang H; Xing F; Meng M; Zou S; Wei W; Chen H; Cai J; Wang H; Zhang H; Cai J; Fang L; Bian X; Chen C; Lan P; Ghesquière B; Fang L; Lee MH
    Cell Res; 2020 Feb; 30(2):163-178. PubMed ID: 31772275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis.
    Li P; Mi Q; Yan S; Xie Y; Cui Z; Zhang S; Wang Y; Gao H; Wang Y; Li J; Du L; Wang C
    Cell Death Dis; 2023 Jan; 14(1):59. PubMed ID: 36697384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.